Bruker Co. (NASDAQ:BRKR) has been assigned an average rating of "Hold" from the twelve ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $59.11.
Several research firms have recently commented on BRKR. Stifel Nicolaus raised their price objective on shares of Bruker from $48.00 to $65.00 and gave the company a "hold" rating in a research note on Wednesday, February 17th. Wells Fargo & Company lowered shares of Bruker from an "overweight" rating to an "equal weight" rating and raised their price objective for the company from $50.00 to $55.00 in a research note on Friday, February 5th. Citigroup raised their price objective on shares of Bruker from $57.00 to $65.00 in a research note on Wednesday, February 17th. Finally, SVB Leerink raised their price objective on shares of Bruker from $50.00 to $70.00 and gave the company an "outperform" rating in a research note on Wednesday, January 27th.
In related news, Director Cynthia M. Friend sold 1,800 shares of the firm's stock in a transaction that occurred on Monday, March 22nd. The shares were sold at an average price of $60.43, for a total value of $108,774.00. Following the sale, the director now owns 10,486 shares of the company's stock, valued at $633,668.98. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 26.80% of the stock is owned by company insiders.
A number of hedge funds have recently added to or reduced their stakes in the business. Global Retirement Partners LLC raised its holdings in Bruker by 28.0% during the fourth quarter. Global Retirement Partners LLC now owns 865 shares of the medical research company's stock worth $47,000 after purchasing an additional 189 shares in the last quarter. Barclays PLC raised its holdings in Bruker by 2.0% during the fourth quarter. Barclays PLC now owns 10,724 shares of the medical research company's stock worth $580,000 after purchasing an additional 211 shares in the last quarter. NEXT Financial Group Inc raised its holdings in Bruker by 128.4% during the first quarter. NEXT Financial Group Inc now owns 450 shares of the medical research company's stock worth $29,000 after purchasing an additional 253 shares in the last quarter. Parallel Advisors LLC raised its holdings in Bruker by 138.4% during the first quarter. Parallel Advisors LLC now owns 441 shares of the medical research company's stock worth $28,000 after purchasing an additional 256 shares in the last quarter. Finally, Great West Life Assurance Co. Can raised its holdings in Bruker by 3.8% during the third quarter. Great West Life Assurance Co. Can now owns 8,418 shares of the medical research company's stock worth $335,000 after purchasing an additional 308 shares in the last quarter. 65.89% of the stock is currently owned by institutional investors.
BRKR stock traded down $0.41 during mid-day trading on Tuesday, hitting $68.24. 10,383 shares of the company were exchanged, compared to its average volume of 471,687. The company has a quick ratio of 1.65, a current ratio of 2.67 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $10.34 billion, a P/E ratio of 67.06, a PEG ratio of 7.11 and a beta of 1.29. The business has a fifty day simple moving average of $65.78 and a 200-day simple moving average of $57.15. Bruker has a 12-month low of $35.98 and a 12-month high of $70.62.
Bruker (NASDAQ:BRKR) last announced its earnings results on Monday, February 15th. The medical research company reported $0.58 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.56 by $0.02. The company had revenue of $627.50 million during the quarter, compared to analyst estimates of $624.80 million. Bruker had a net margin of 8.04% and a return on equity of 21.78%. Research analysts predict that Bruker will post 1.33 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, March 19th. Investors of record on Friday, March 5th were issued a $0.04 dividend. The ex-dividend date of this dividend was Thursday, March 4th. This represents a $0.16 annualized dividend and a yield of 0.23%. Bruker's dividend payout ratio (DPR) is 10.19%.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Recommended Story: What are municipal bonds?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: How To Calculate Debt-to-Equity Ratio7 Electric Vehicle (EV) Stocks That Are Ready to Rebound
The electric vehicle (EV) sector was nearly as frothy as the “pandemic stocks” in 2020. It wasn’t that the EV sector was dormant during the Trump administration.
But, as the saying goes, elections have consequences. And Wall Street understands they can make money in any administration. And as a bet that Joe Biden would win the presidency, electric vehicle stocks soared.
For starters, the Biden administration has already said it will prioritize climate change like no administration ever has. And one way they are going to do that is to incentivize the production and purchase of electric vehicles.
And to take advantage of this shift towards electric vehicle stocks, many private companies raced to get in on the action. The preferred way for many of these companies to go public was via a Special Purpose Acquisition Company (SPAC). A SPAC is basically a shortcut to the traditional IPO process.
However, what goes up frequently goes down and since late February, EV stocks have been getting battered. But this is creating an opportunity because the electric vehicle is still supposed to see exceptional growth over the next five years.
To help you take advantage of this we’ve created this special presentation that includes seven stocks that appear to be ready to take the next leg up.
View the "7 Electric Vehicle (EV) Stocks That Are Ready to Rebound "